Carrie Judy, MD
Family Medicine · Sumter, SCNPI 1932195559
Payments from drug & device makers
Across 182 payments — averaging $15.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$329
- Amgen$263
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$261
- Pfizer$252
- Boehringer Ingelheim$248
- Novo Nordisk$198
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,883100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 24 | $329 |
| Amgen | 16 | $263 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $261 |
| Pfizer | 18 | $252 |
| Boehringer Ingelheim | 15 | $248 |
| Novo Nordisk | 14 | $198 |
| Sanofi-aventis U.S. LLC | 9 | $151 |
| Lilly USA, LLC | 11 | $144 |
| AbbVie(2 entities) | 7 | $115 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $106 |
| Merck | 7 | $96 |
| GSK | 7 | $93 |
| Abbott | 5 | $86 |
| Novartis | 4 | $82 |
| Kowa Pharmaceuticals America, Inc. | 6 | $73 |
| Eisai Inc. | 3 | $54 |
| E.r. Squibb & Sons, L.L.C. | 2 | $53 |
| Insulet Corporation | 1 | $49 |
| Amarin Pharma, Inc. | 3 | $45 |
| Edwards Lifesciences | 2 | $38 |
| Esperion Therapeutics, Inc. | 1 | $25 |
| Arbor Pharmaceuticals, Inc. | 1 | $21 |
| IBSA Pharma Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Optinose US, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Bayer | 1 | $12 |
| Currax Pharmaceuticals LLC | 1 | $11 |
How this compares
$2,883 in reported general payments places this provider in the 75th percentile of 2,153 family medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 62 | $75,052 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $36,247 |
| OzempicSemaglutide | 23 | $34,589 |
| JanuviaSitagliptin Phosphate | 34 | $32,526 |
| LinzessLinaclotide | 13 | $21,127 |
| EliquisApixaban | 24 | $15,930 |
| Spiriva RespimatTiotropium Bromide | 11 | $15,785 |
| XareltoRivaroxaban | 13 | $12,188 |
| Repatha SureclickEvolocumab | 13 | $11,086 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 15 | $3,860 |
| Pitavastatin Calcium | 11 | $3,701 |
| Atorvastatin Calcium | 221 | $2,754 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 41 | $1,768 |
| Fluticasone Propionate | 74 | $1,455 |
| Amlodipine Besylate | 175 | $1,449 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $144 | $75,05262 claims |
| GSKTrelegy Ellipta | $93 | $36,24728 claims |
| Novo NordiskOzempic | $198 | $34,58923 claims |
| MerckJanuvia | $96 | $32,52634 claims |
| AbbVieLinzess | $115 | $21,12713 claims |
| PfizerEliquis | $252 | $15,93024 claims |
| Boehringer IngelheimSpiriva Respimat | $248 | $15,78511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Sumter
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.